Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Study APV20002: Safety and Efficacy Results Through Week 684 for Pediatric Participants Living with HIV-1 Treated with Ritonavir-Boosted Fosamprenavir Oral Solution-Based Antiretroviral Therapy.
Journal: AIDS research and human retroviruses
Published: July 08, 2024
Neonatal morbidity and mortality in birth centers in the United States 2018-2021: An observational study of low-risk birthing individuals.
Journal: Birth (Berkeley, Calif.)
Published: July 19, 2023
Strong Start Innovation: Equitable Outcomes Across Public and Privately Insured Clients Receiving Birth Center Care.
Journal: Journal of midwifery & women's health
Published: February 28, 2022
Salary and Workload of Midwives Across Birth Center Practice Types and State Regulatory Structures.
Journal: Journal of midwifery & women's health
Published: May 07, 2021
Assessment of drug interaction potential between the HCV direct-acting antiviral agents elbasvir/grazoprevir and the HIV integrase inhibitors raltegravir and dolutegravir.
Journal: The Journal of antimicrobial chemotherapy
Published: May 21, 2018
Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States.
Journal: AIDS research and human retroviruses
Published: May 08, 2018
Similar neurocognitive outcomes after 48 weeks in HIV-1-infected participants randomized to continue tenofovir/emtricitabine + atazanavir/ritonavir or simplify to abacavir/lamivudine + atazanavir.
Journal: Journal of neurovirology
Published: April 19, 2018
Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks.
Journal: HIV/AIDS (Auckland, N.Z.)
Published: April 21, 2017
Erratum to: A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir.
Journal: Clinical pharmacokinetics
Published: February 11, 2017
A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir.
Journal: Clinical pharmacokinetics
Published: October 05, 2016
HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects.
Journal: BMC infectious diseases
Published: September 07, 2016
Last Updated: 09/26/2026